Video - European Medical Journal

Continue

Videos

EMJ
Oncology
23 Jul 2015

Phase 3 trial of fulvestrant with palbociclib for metastatic breast cancer

At the 2015 American Society of Clinical Oncology (ASCO) Annual Meeting, Nicholas Turner, MD, PhD, of the Institute of Cancer Research and Royal Marsden…
EMJ
Dermatology
14 Jul 2015

Supporting CKD Patients at Home

Baxter Symposium from the 52nd European Renal Association – European Dialysis and Transplant Association Congress 2015.
EMJ
Oncology
13 Jul 2015

The impact of the Oncotype DX® Recurrence Score® on treatment decisions in breast cancer patients

The results of the Oncotype DX® Breast Cancer Assay are reported as a Recurrence Score® – a number ranging from 0 to 100. This number indicates the…
EMJ
Oncology
10 Jul 2015

Molecular characterisation of kidney cancer and opportunities for targeted therapies

At the 2015 American Society of Clinical Oncology (ASCO) Annual Meeting, Sumanta K. Pal, MD, of City of Hope Comprehensive Cancer Center, Duarte, CA…
EMJ
Oncology
10 Jul 2015

Emerging targeted therapies in haematological malignancies

At the 2015 American Society of Clinical Oncology (ASCO) Annual Meeting, Julie M. Vose, MD, MBA, of the University of Nebraska Medical Center, Omaha, NE…
EMJ
Oncology
10 Jul 2015

New strategies in the treatment of multiple myeloma

Ola Landgren, MD, PhD, of Memorial Sloan Kettering Cancer Center, New York, NY, reviews the new data presented at the 2015 American Society of Clinical…
EMJ
Oncology
10 Jul 2015

STRIDE: Phase 2 study of sipuleucel-T in metastatic castration-resistant prostate cancer

At the 2015 American Society of Clinical Oncology (ASCO) Annual Meeting, Neal Shore, MD, FACS, of Atlantic Urology Clinics, Myrtle Beach, SC, discusses…
EMJ
Oncology
10 Jul 2015

Julie M. Vose, MD, MBA, FASCO, elected ASCO President for 2015–2016 term

At the 2015 American Society of Clinical Oncology (ASCO) Annual Meeting, elected ASCO President for the 2015–2016 term, Julie M. Vose, MD, MBA, of the…